Congresses and Meetings

New long-term data from the DIVERGE study, presented at this week’s EuroPCR 2013 congress has shown that the use of … continue reading “Five Year Data For Axxess™ Self-Expanding Bifurcation DES”

Optical Biopsies captured with Mauna Kea Technologies’ new AQ-Flex™ 19 Miniprobe were deemed easy to interpret with short learning curve for both novice and expert endoscopists according to data presented at Digestive Disease Week 2013

It’s Digestive Disease Week(DDW) in Orlando’s Orange County Convention Center. At the event, PillCam capsule endoscopy pioneer Given Imaging Ltd, has … continue reading “PillCam Starting To Look Like A Diagnostic Option Say Studies”

Stent maker Biosensors,  tells us that new registry data presented this week at EuroPCR 2013 has confirmed that the BioMatrix™ … continue reading “Could New BioMatrix™ DES 5000 Patient Registry Data Result In Shorter DAPT Course?”

This week’s EuroPCR event saw the publication of a study in which patients were treated with the Direct Flow Medical® Transcatheter Aortic Valve System. The DISCOVER Trial full 30-day outcomes suggested minimal post-procedural aortic regurgitation and adverse events.

With EuroPCR* taking place any day, now seems a good time for companies to be previewing their offerings and debuting … continue reading “St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement”

This week sees the annual running of the Arthroscopy Association of North America (AANA) meeting. The event, which takes place from April 25-27, takes place in San Antonio, Texas and comprises its usual healthy treatment of all things arthroscopy.

Positive three-month data for Vent-Os chronic sinusitis device have been presented at this week’s Combined Otolaryngology Spring Meeting in Orlando. The device offers an alternative to rapid, high pressure balloon inflation treatment.

At last week’s Annual German Cardiac Society meeting Swiss transcatheter valve developer Symetis saw registry data from the Symetis ACURATE TA™ Valve Implantation (SAVI) Registry presented. Low leakage and mortality reported.

This weekend (April 6-9) sees the 35th running of the Charing Cross Vascular Symposium in London. Medtronic has just received CE mark approval for its new AAA stent graft introducer sheath and will be showcasing it among its other offerings at the event.

AAOS is as good a place as any to draw attention to one’s products and Integra has taken the opportunity to remind us just how successful its IPP-ON PIP Fusion device has been as it announces reaching 4000 hammertoe correction cases.

It’s AAOS week, and Mitek Sports Medicine has chosen the event for the launch of the MILAGRO® Advance Interference Screw, a new biocomposite screw designed to offer easier and faster insertion when compared to traditional interference screws.

March 19th-3rd sees this year’s American Academy of Orthopaedic Surgeons congress taking place in Chicago Illinois. According to the congress … continue reading “AAOS 2013 This Week”

Transcatheter heart valve company Direct Flow Medical®, Inc., has been trumpeting the DISCOVER Trial results presented Sunday at the American College of Cardiology (ACC) Annual Meeting. Patients treated with the Direct Flow Medical® Transcatheter Aortic Valve System achieved excellent survivability and sustained hemodynamic improvements with minimal occurrence of aortic regurgitation at six months.

Two interesting clinical trials were reported at ACC Scientific Sessions last weekend. Firstly Edwards Lifesciences’ Sapien XT seemed to offer improvements in rate of vascular events compared with its big brother. Also, in the pivotal PARTNER study of Sapien, results were comparable with conventional surgery despite ongoing high comparative incidence of paravalvular leakage.

Organisers pulled the PREVAIL study into the Watchman Left Atrial Appendage occlusion device from its allotted slot in the late-breakers clinical session, as well as its associated press conference because Boston Scientific broke its embargo by releasing the data early by email.